← Browse by Condition
Medical Condition
attention deficit hyperactivity disorder
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2, Phase 4
ClinicalMetric tracks all active clinical trials for attention deficit hyperactivity disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — attention deficit hyperactivity disorder Clinical Trials
How many clinical trials are currently recruiting for attention deficit hyperactivity disorder?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for attention deficit hyperactivity disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for attention deficit hyperactivity disorder?
attention deficit hyperactivity disorder research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a attention deficit hyperactivity disorder clinical trial?
Eligibility criteria for attention deficit hyperactivity disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06373484
Recruiting
Enrollment
200 pts
Location
Canada
Sponsor
Centre for Addiction and Menta...
NCT07203092
Recruiting
Enrollment
140 pts
Location
United States
Sponsor
Francisco Gonzalez-Lima, PhD
NCT06115603 Phase 2
Recruiting
Enrollment
76 pts
Location
United States
Sponsor
University of Arkansas, Fayett...
NCT07242625
Recruiting
Enrollment
48 pts
Location
South Korea
Sponsor
Neudive Inc.
NCT07439276
Recruiting
Enrollment
100 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT03420339 Phase 4
Recruiting
Enrollment
10 pts
Location
United States
Sponsor
Matthew J O'Brien, PhD, BCBA-D
NCT06232226
Recruiting
Enrollment
80 pts
Location
France
Sponsor
Nantes University Hospital
NCT06194162
Recruiting
Enrollment
340 pts
Location
Denmark
Sponsor
University Hospital Bispebjerg...
Related Conditions
autism spectrum disorder (2) neurodevelopmental disorders (2) disruptive behavior disorder (1) emotional disorder (1) behavioural disorder (1) conduct disorder (1) oppositional defiant disorder (1) atypical neurodevelopmental disorder (1) problem behavior (1) behavior hyperactive (1) behavior disorders (1) attention deficit hyperactivity (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology